R. Kientsch-Engel

747 total citations
18 papers, 535 citations indexed

About

R. Kientsch-Engel is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, R. Kientsch-Engel has authored 18 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Biochemistry, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Immunology. Recurrent topics in R. Kientsch-Engel's work include Advanced Glycation End Products research (7 papers), Diabetes and associated disorders (3 papers) and Alzheimer's disease research and treatments (2 papers). R. Kientsch-Engel is often cited by papers focused on Advanced Glycation End Products research (7 papers), Diabetes and associated disorders (3 papers) and Alzheimer's disease research and treatments (2 papers). R. Kientsch-Engel collaborates with scholars based in Germany, United States and Australia. R. Kientsch-Engel's co-authors include G. E. Lang, Günter Lang, B. O. Boehm, Sybille Franke, G Stein, Silke Rosinger, Stephan Schilling, Monika Pischetsrieder, Peter Lasch and S. A. Muller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Diabetologia.

In The Last Decade

R. Kientsch-Engel

17 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kientsch-Engel Germany 11 262 154 89 87 69 18 535
C He France 8 364 1.4× 221 1.4× 105 1.2× 46 0.5× 32 0.5× 10 650
Masahiko Kushiro Japan 10 249 1.0× 145 0.9× 117 1.3× 52 0.6× 65 0.9× 13 675
Paul L. van Haelst Netherlands 13 124 0.5× 91 0.6× 66 0.7× 35 0.4× 151 2.2× 21 766
Fabio Gianiorio Italy 9 95 0.4× 94 0.6× 156 1.8× 63 0.7× 101 1.5× 10 706
Naoya Igaki Japan 14 160 0.6× 171 1.1× 71 0.8× 25 0.3× 71 1.0× 42 525
Kensei Taguchi Japan 15 150 0.6× 86 0.6× 93 1.0× 41 0.5× 55 0.8× 38 680
Maria Arriero Spain 11 366 1.4× 134 0.9× 141 1.6× 25 0.3× 68 1.0× 15 682
Nektaria Papadopoulou‐Marketou Greece 10 85 0.3× 243 1.6× 75 0.8× 115 1.3× 135 2.0× 20 741
Maria Knapik‐Kordecka Poland 12 113 0.4× 98 0.6× 64 0.7× 18 0.2× 51 0.7× 26 437
Takashi Shimotomai Japan 10 74 0.3× 105 0.7× 73 0.8× 44 0.5× 55 0.8× 13 534

Countries citing papers authored by R. Kientsch-Engel

Since Specialization
Citations

This map shows the geographic impact of R. Kientsch-Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kientsch-Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kientsch-Engel more than expected).

Fields of papers citing papers by R. Kientsch-Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kientsch-Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kientsch-Engel. The network helps show where R. Kientsch-Engel may publish in the future.

Co-authorship network of co-authors of R. Kientsch-Engel

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kientsch-Engel. A scholar is included among the top collaborators of R. Kientsch-Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kientsch-Engel. R. Kientsch-Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kientsch-Engel, R., et al.. (2015). Methods for Measuring Erythropoietin and Erythropoietin Antibodies Using ELISA Technique. Contributions to nephrology. 76. 100–105.
2.
Schley, Gunnar, et al.. (2015). Comparative analysis of diagnostic and predictive performance of novel renal biomarkers in plasma and urine of acute kidney injury patients. Intensive Care Medicine Experimental. 3(S1). 1 indexed citations
3.
Schiekofer, Stephan, Silvia Isabel Rech Franke, M. Andrassy, et al.. (2006). Postprandial Mononuclear NF-κB Activation is Independent of the AGE-content of a Single Meal. Experimental and Clinical Endocrinology & Diabetes. 114(4). 160–167. 14 indexed citations
4.
Kientsch-Engel, R., et al.. (2005). Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clinical Chemistry and Laboratory Medicine (CCLM). 43(5). 503–11. 43 indexed citations
5.
Webster, Julie A., et al.. (2005). Maillardprodukte aus Lebensmitteln als pro-entzündliche und pro-arteriosklerotische Faktoren bei degenerativen Erkrankungen. Zeitschrift für Gerontologie und Geriatrie. 38(5). 347–353. 5 indexed citations
6.
Schiel, Ralf, Silvia Isabel Rech Franke, Ulrich Voigt, et al.. (2004). Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN).. PubMed. 9(8). 391–9. 12 indexed citations
7.
8.
Kientsch-Engel, R., et al.. (2004). Determination of Glycated Nucleobases in Human Urine by a New Monoclonal Antibody Specific for N2-Carboxyethyl-2‘-deoxyguanosine. Chemical Research in Toxicology. 17(10). 1385–1390. 36 indexed citations
9.
Boehm, B. O., Stephan Schilling, Silke Rosinger, et al.. (2004). Elevated serum levels of N?-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia. 47(8). 1376–9. 102 indexed citations
10.
Franke, Sybille, Andreas Müller, Manfred Sommer, et al.. (2003). Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation. Clinical Nephrology. 59(2). 88–97. 32 indexed citations
11.
Bär, Karl‐Jürgen, Sybille Franke, S. A. Muller, et al.. (2002). Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementia. Neurobiology of Aging. 24(2). 333–338. 69 indexed citations
12.
Beales, P. E., et al.. (2000). Intradermal Administration of GAD & Evaluation of Diabetes Incidence in Mice: Possible Relevance for Skin Tests in Humans. Autoimmunity. 32(2). 109–113. 1 indexed citations
13.
Kientsch-Engel, R., et al.. (1997). No induction of antibodies in patients treated with the recombinant plasminogen activator reteplase (BM 06.022). Fibrinolysis & proteolysis. 11(5-6). 259–264. 1 indexed citations
14.
15.
16.
Richter, Wiltrud, Josef Endl, Thomas Eiermann, et al.. (1992). Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.. Proceedings of the National Academy of Sciences. 89(18). 8467–8471. 74 indexed citations
17.
Martin, Ulrich, E von Möllendorff, W. Akpan, et al.. (1991). Pharmacokinetic and Hemostatic Properties of the Recombinant Plasminogen Activator BM 06.022 in Healthy Volunteers. Thrombosis and Haemostasis. 66(5). 569–574. 45 indexed citations
18.
Kientsch-Engel, R., et al.. (1990). New Enzyme-Linked Immunosorbent Assay Methods for Measurement of Serum Erythropoietin Levels and Erythropoietin Antibodies. Blood Purification. 8(5). 255–259. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C He Breakdown of academic impact, for papers by Masahiko Kushiro Breakdown of academic impact, for papers by Paul L. van Haelst Breakdown of academic impact, for papers by Fabio Gianiorio Breakdown of academic impact, for papers by Naoya Igaki Breakdown of academic impact, for papers by Kensei Taguchi Breakdown of academic impact, for papers by Maria Arriero Breakdown of academic impact, for papers by Nektaria Papadopoulou‐Marketou Breakdown of academic impact, for papers by Maria Knapik‐Kordecka Breakdown of academic impact, for papers by Takashi Shimotomai
Rankless by CCL
2026